No abstract available
Publication types
-
Clinical Trial, Phase III
-
Research Support, Non-U.S. Gov't
MeSH terms
-
Antibodies, Monoclonal / pharmacology
-
Antibodies, Monoclonal / therapeutic use*
-
Antineoplastic Agents / pharmacology
-
Antineoplastic Agents / therapeutic use*
-
Humans
-
Multiple Myeloma / drug therapy*
-
Multiple Myeloma / mortality
-
Progression-Free Survival
Substances
-
Antibodies, Monoclonal
-
Antineoplastic Agents
-
daratumumab